Top compounds associated with response to CHD2


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00097 1
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.00091 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.00093 1
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.00088 1
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.00078 1
mRNA rTRAIL GDSC1000 pan-cancer AAC -0.0008 1
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.00076 1
mRNA CAY10594 CTRPv2 pan-cancer AAC -0.00078 1
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.00065 1
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.00072 1
Download CSV